Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mohamed El Kassas, Mohamed Eltabbakh, Mohamed Elbadry, Ahmed Tawheed & Tamer Elbaz. (2022) Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center. Current Medical Research and Opinion 38:4, pages 553-563.
Read now
Read now
Mohamed El Kassas, Eman Salah, Aya Gad & Ahmed Hosny. (2021) Improvement of sexual dysfunction in patients after treatment of hepatitis C virus using directly acting antivirals. Current Medical Research and Opinion 37:6, pages 967-972.
Read now
Read now
Gamal Esmat, Tamer Elbaz, Aisha Elsharkawy, Mohamed Abdullah & Mohamed El Kassas. (2020) Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt. Expert Review of Anti-infective Therapy 18:7, pages 637-642.
Read now
Read now
Mohamed El Kassas, Ahmed Tawheed, Mohamed Eltabbakh & Ahmed Kaseb. (2019) Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves. Journal of Hepatocellular Carcinoma 6, pages 183-191.
Read now
Read now
Mohamed El Kassas, Mohamed Alboraie, Dalia Omran, Mohamed Salaheldin, Mohamed Naguib Wifi, Mohamed ElBadry, Adel El Tahan, Sameera Ezzat, Enass Moaz, Amir M Farid, Heba Omar, Mahmoud Abouelkhair, Shimaa Afify, Kadry Elsaeed, Yehia Shazly, Wahid Doss & Gamal Esmat. (2018) An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens. Expert Review of Gastroenterology & Hepatology 12:12, pages 1265-1272.
Read now
Read now
Mohamed El Kassas, Tamer Elbaz, Aisha Elsharkawy, Heba Omar & Gamal Esmat. (2018) HCV in Egypt, prevention, treatment and key barriers to elimination. Expert Review of Anti-infective Therapy 16:4, pages 345-350.
Read now
Read now
Ghada El Sagheer, Elwy Soliman, Asmaa Ahmad & Lamiaa Hamdy. (2018) Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs. Libyan Journal of Medicine 13:1.
Read now
Read now
Articles from other publishers (23)
Mohamed El-Kassas, Amira El Balakosy, Mohamed Elbadry, Ossama Ashraf Ahmed, Christina Alphonse Anwar, Mohammad Abd Algaber, Tari George Michael, Adel El Tahan, Mohamed Alborai, Gina Meleak, Maraw Tahoon, Ahmed Sherief, Khaled Raafat, Hend Radwan, Basem Eysa, Haitham Ezzat Abdelaziz, Yasmeen Ahmed, Mohammed Aboul-Ezz & Abeer Awad. (2023) The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study. Clinics and Research in Hepatology and Gastroenterology 47:10, pages 102232.
Crossref
Crossref
Walaa Abdelhamed & Mohamed El‐Kassas. (2022) Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful. Journal of Viral Hepatitis 30:2, pages 148-159.
Crossref
Crossref
Mohamed El-Kassas, Runia El-Folly, Maram Aboromia, Heba Aly, Mohamed Bahgat & Mostafa Hamed. (2022) Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection. Egyptian Liver Journal 12:1.
Crossref
Crossref
Mohamed El-Kassas, Sherif Elbehiry, Enas Rezk, Dalia Omran, Ahmed Sherief, Mohamed Eltabbakh, Inas Moaz, Adel TEl ahan, Mohammad Abdalgaber, Haidy Khalil, Mohamed Alboraie, Amr El Fouly, Mohammed Aboul-Ezz, Amany Wahb & Ahmed Madkour. (2022) Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event. Clinics and Research in Hepatology and Gastroenterology 46:10, pages 102042.
Crossref
Crossref
Aisha Elsharkawy, Reham Samir & Mohamed El-Kassas. (2022) Fibrosis regression following hepatitis C antiviral therapy. World Journal of Hepatology 14:6, pages 1120-1130.
Crossref
Crossref
Mohamed El-Kassas & Abeer Awad. (2022) Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 28:22, pages 2429-2436.
Crossref
Crossref
Mohamed El Kassas, Mohamed Alboraie, Heba Omar, Yasmeen Abd El Latif, Mohammed Abd Algaber, Adel El Tahan, Hesham El Halwagy, Shimaa Afify, Magdy Elserafy, Kadry Elsaeed & Wahid Doss. (2019) High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results. Journal of Medical Virology 94:2, pages 667-674.
Crossref
Crossref
Mohamed El Kassas, Nermeen Abdeen, Dalia Omran, Mohamed Alboraie, Mohamed Salaheldin, Mohamed Eltabbakh, Rasha Farghaly, Mohammed Emadeldeen, Shimaa Afify, Ahmad Sweedy, Ahmed Ghalwash, Amr Abbass, Sameera Ezzat, Marwa Tahoon, Helmy M. ELshazly, Hassan Hamdy & Heba Omar. (2021) Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis. European Journal of Gastroenterology & Hepatology 33:1S, pages e877-e882.
Crossref
Crossref
Mohamed El Kassas, Mohamed Alboraie, Mohammad El-Sayed, Sherif Elbehiry, Ahmed Sherief, Mohamed Youssef, Inas Moaz, Adel El Tahan, Nermeen Abdeen, Basem Eysa, Ayman A. Aziz, Ahmed Tawheed, Sameera Ezzat & Mohamed Hassany. (2021) Effect of disease stage and treatment outcomes on the dynamics of liver functions during and after treatment of hepatitis C with directly acting antivirals. European Journal of Gastroenterology & Hepatology 33:1S, pages e302-e307.
Crossref
Crossref
Mohamed El Kassas, Osama MO Hegazy & Eman M Salah. (2020) Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations. World Journal of Hepatology 12:10, pages 841-849.
Crossref
Crossref
Mohamed El Kassas, Mohamed Alboraie, Mohamed El Badry, Naglaa Youssef, Heba Omar, Reem Y. El Sheemy, Amira Al Balakosy, Ossama Ashraf Ahmed Mohamed, Gina Gamal Naguib Meleak, Hany Dabbous, Mohamed Hassan Ahmed Fouad, Mohamed-Naguib Wifi, Samy Zaky, Marwa Tahoon, Adel El Tahan, Fathiya El-Raey, Sameera Ezzat & Wahid Doss. (2020) Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study. International Journal of Infectious Diseases 96, pages 367-370.
Crossref
Crossref
Ahmed E. Gaafar, Amr Abd El-Aal, Mohamed Alboraie, Housam M. Hassan, Adel ElTahan, Yasser AbdelRahman, Mohamed-Naguib Wifi, Dalia Omran, Shimaa Afify Mansour, Waleed M. Hassan, Magdy Ismail & Mohamed El Kassas. (2019) Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease. The Egyptian Heart Journal 71:1.
Crossref
Crossref
Gamal Soliman, Mahmoud S. Elzalabany, Tarek Hassanein & F. DeWolfe Miller. (2019) Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 19:1.
Crossref
Crossref
Daniel Esteban Pino Marín, Pedro Amariles, Jaime Alberto Peláez Alvárez, Gloria Priscilla Alvárez Osorio & Juliana González Ceballos. (2019) Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de hepatitis C, revisión estructurada (actualización 2015 – 2017). Revista Colombiana de Gastroenterología 34:2, pages 159-176.
Crossref
Crossref
Sameh A. Lashen, Mohammed M. Shamseya, Marwa A. Madkour & Galal A. Aboufarrag. (2019) Tolerability and effectiveness of generic direct‐acting antiviral drugs in eradication of hepatitis C genotype 4 among Egyptian patients. Liver International 39:5, pages 835-843.
Crossref
Crossref
Mohamed El Kassas, Reem El Sheemy, Mohamed Alboraie, Mohamed El Badry, Mohamed Naguib Wifi, Naglaa Youssef, Sameera Ezzat, Marwa Tahoon, Lobna Abdelsalam, Sara M. Abdelhakam & Zainab Ali-Eldin. (2019) Real-world results of direct-acting antivirals use for the treatment of chronic hepatitis C in old patients. European Geriatric Medicine 10:2, pages 295-302.
Crossref
Crossref
Ernest Asante-Appiah, Rong Liu, Stephanie Curry, Patricia McMonagle, Sony Agrawal, Donna Carr, Laura Rokosz, Frederick Lahser, Karin Bystol, Robert Chase, Stuart Black, Eric Ferrari, Paul Ingravallo, Ling Tong, Wensheng Yu & Joseph Kozlowski. (2018)
In Vitro
Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A
. Antimicrobial Agents and Chemotherapy 62:11.
Crossref
Crossref
David A. DeGoey, Hui-Ju Chen, Philip B. Cox & Michael D. Wendt. (2017) Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection. Journal of Medicinal Chemistry 61:7, pages 2636-2651.
Crossref
Crossref
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen & Salman Nusrat. (2018) Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. European Journal of Gastroenterology & Hepatology 30:3, pages 296-301.
Crossref
Crossref
Mohamed El KassasDalia OmranKadry ElsaeedMohamed AlboraieWafaa ElakelAdel El TahanYasmeen Abd El LatifMohamed Mahmoud NabeelMohamed KoranySameera EzzatMagdy El-SerafyYehia ElShazlyWahid DossGamal Esmat. (2018) Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research 38:2, pages 81-85.
Crossref
Crossref
Gamal Esmat, Tamer Elbaz, Maissa El Raziky, Asmaa Gomaa, Mahmoud Abouelkhair, Hadeel Gamal El Deen, Aliaa Sabry, Mohamed Ashour, Naglaa Allam, Mohamed Abdel-Hamid, Ola Nada, Sherine Helmy, Hanaa Abdel-Maguid, Richard Colonno, Nathaniel Brown, Eric Ruby, Pamela Vig & Imam Waked. (2018) Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4. Journal of Hepatology 68:1, pages 53-62.
Crossref
Crossref
Longbo Hu, Jinqian Li, Hua Cai, Wenxia Yao, Jing Xiao, Yi-Ping Li, Xiu Qiu, Huimin Xia & Tao Peng. (2017) Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles. Antiviral Research 148, pages 5-14.
Crossref
Crossref
Kelvin Nguyen, Melissa Jimenez, Nima Moghadam, Crystal Wu, Alex Farid, Jonathan Grotts, David Elashoff, Gina Choi, Francisco A. Durazo, Mohamed M. El-Kabany, Steven-Huy B. Han & Sammy Saab. (2017) Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. Journal of Clinical and Translational Hepatology XX:XX, pages 1-7.
Crossref
Crossref